Akron Children's recently partnered with Sonar Mental Health, which offers 24/7 text-based mental health support.

Bays Mountain Park has announced the return of “Dark Matter Mystery – Exploring a Cosmic Secret” to the planetarium theater.

One year after receiving three doses of a custom-built CRISPR base-editing therapy at Children’s Hospital of Philadelphia, ...

Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

The FDA approved the expansion of Casgevy, which had previously been greenlit for patients 12 and up, into a younger pediatric population under the agency’s Commissioner’s National Priority Voucher ...

The Food and Drug Administration this week cleared a second carcass-feasting fly species for use in maggot wound therapy, according to an announcement from Cuprina Holdings, a Singapore-based company ...

Patients leaving the hospital with severe infections requiring prolonged antibiotic treatment face significant risks without vigilant monitoring, especially where access to infectious disease ...

Nate and Jackie Barrington often rely on technology to communicate with their 20-year-old son, Ian. Ian, who is on the autism spectrum, can understand his parents. But he struggles with communicating ...

An 8-month-old infant with severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene ...

MONROE, La. (KTVE/KARD) – The University of Louisiana Monroe’s Marjorie S. Price Doctor of Physical Therapy program has received full accreditation from the Commission on Accreditation in Physical ...

Dravet syndrome has long represented one of the most challenging pediatric epilepsies encountered in neurology and genetic medicine. Caused primarily by loss‑of‑function variants in SCN1A, the ...